MedPath

Myelo Therapeutics GmbH

Myelo Therapeutics GmbH logo
🇩🇪Germany
Ownership
Subsidiary
Established
2013-01-01
Employees
1
Market Cap
-
Website
http://www.myelotherapeutics.com

Clinical Trials

3

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 1
1 (33.3%)

Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia

Phase 2
Completed
Conditions
Chemotherapy-Induced Neutropenia
Myelosuppression
Breast Cancer
Interventions
Drug: Placebo
First Posted Date
2016-02-26
Last Posted Date
2017-11-24
Lead Sponsor
Myelo Therapeutics GmbH
Target Recruit Count
137
Registration Number
NCT02692742
Locations
🇩🇪

Site 20, Aachen, Germany

🇩🇪

Site 16, Aurich, Germany

🇩🇪

Site 21, Dresden, Germany

and more 20 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.